Contacts and Statements Sample Clauses

Contacts and Statements. Contacts with the applicable governmental agency with respect to this Agreement shall be coordinated between Acura and Bayer. The Parties shall mutually agree to the responsible Party for initiating such contact. All public statements regarding Bayer trademarks will be the responsibility solely of Bayer. Where practical, all such statements will be provided to Acura for content review prior to release.
AutoNDA by SimpleDocs
Contacts and Statements. With respect to any recall, withdrawal, ----------------------- field correction or field alert report with respect to any Product, GWI shall make all contacts with the FDA and shall be responsible for coordinating all of the necessary activities in connection with any such recall, withdrawal, field correction or field alert report, and GWI shall make all statements to the media, including press releases and interviews for publication or broadcast as provided in
Contacts and Statements. With respect to any recall, withdrawal, field correction, field alert report or comparable report with respect to any Product, Amarin or its designee shall make all contacts with the applicable Governmental Body and shall be responsible for coordinating all of the necessary activities in connection with any such recall, withdrawal, field correction, field alert report or comparable report. Amarin or its designee shall make all statements to the media, including press releases and interviews for publication or broadcast. Chemport agrees to make no statement to the media, unless otherwise required by Legal Requirements, and, in any such event, Chemport shall reasonably collaborate with Amarin on the content of any such statement.
Contacts and Statements. With respect to any recall, withdrawal, field correction or field alert report with respect to any Agreement Product SuperGen shall make all contacts with the FDA and shall be responsible for coordinating all of the necessary activities in connection with any such recall, withdrawal, field correction or field alert report. Pharmachemie agrees to make no statement to the media, unless otherwise required by law and in any such event, Pharmachemie shall collaborate with SuperGen on the content of any such statement.
Contacts and Statements. With respect to any recall, withdrawal, field correction, field alert report or comparable report with respect to Product, Inspire or its designee shall make all contacts with the applicable Governmental Body and shall be responsible for coordinating all of the necessary activities in connection with any such recall, withdrawal, field correction, field alert report or comparable report. Inspire or its designee shall make all statements to the media, including press releases and interviews for publication or broadcast. Novasep agrees to make no statement to the media, unless otherwise required by law and in any such event, Novasep shall collaborate with Inspire on the content of any such statement.
Contacts and Statements. With respect to any recall, withdrawal, field correction, field alert report or comparable report with respect to Product, Amarin or its designee shall make all contacts with the applicable Governmental Body and shall be responsible for coordinating all of the necessary activities in connection with any such recall, withdrawal, field correction, field alert report or comparable report. Amarin or its designee shall make all statements to the media, including press releases and interviews for publication or broadcast. Equateq agrees to make no statement to the media, unless otherwise required by law and in any such event, Equateq shall collaborate with Amarin on the content of any such statement.
Contacts and Statements. For any recall, withdrawal, field correction, field alert report or comparable report for any Product, XenoPort will make all contacts with the applicable Governmental Authority or Regulatory Authority and will be responsible for coordinating all of the necessary activities in connection with any such recall, withdrawal, field correction, field alert report or comparable report, and XenoPort will make all statements to the media, including press releases and interviews for publication or broadcast. Patheon agrees to make no statement to the media, unless otherwise required by Laws and, in any such event, Patheon will collaborate with XenoPort on the content of any statement.
AutoNDA by SimpleDocs
Contacts and Statements. With respect to any Remedial Action in the Licensed Territory with respect to any Product, GSK shall make all contacts with the applicable Governmental Authority or Regulatory Authority and shall be responsible for coordinating all of the necessary activities in connection with any such Remedial Action, and GSK shall make all statements to the media, including press releases and interviews for publication or broadcast as provided in Section 11.4 of the License Agreement. GSK agrees to make no statement to the media referencing Impax or the Facility, unless otherwise required by Laws and, in any such event, GSK shall provide notice to and collaborate with Impax on the content of any such Impax reference. Impax agrees to make no statement to the media referencing GSK with respect to any Remedial Action in the Licensed Territory unless otherwise required by Laws and, in any such event, Impax shall collaborate with GSK on the content of any such statement.
Contacts and Statements. With respect to any Recall, Withdrawal, field correction, field alert report or comparable report with respect to any Product(s), Banner shall consult with JDS and Banner shall make all contacts with the applicable Governmental Body and shall be responsible for coordinating all of the necessary activities in connection with any such Recall, Withdrawal, field correction, field alert report or comparable report. Banner and JDS shall meaningfully consult with each other with respect to statements to the media made by JDS and/or Banner, including press releases and interviews for publication or broadcast, but Banner as the NDA owner, acting reasonably and in good faith, shall have the right of final approval of such media statements.
Contacts and Statements. With respect to any recall, withdrawal, field correction, field alert report or comparable report with respect to any Product, GSK shall make all contacts with the applicable Governmental Authorities and shall be responsible for coordinating all of the necessary activities in connection with any such recall, withdrawal, field correction, field alert report or comparable report, and GSK shall make all statements to the media, including press releases and interviews for publication or broadcast as provided in Section 13.6 below. Draxis agrees to make no statement to the media, unless otherwise required by law and in any such event, Draxis shall collaborate with GSK on the content of any such statement.
Time is Money Join Law Insider Premium to draft better contracts faster.